ArticleClinical ophthalmology (Auckland, N.Z.)2025
Ray Visualization and Through-Focus Optical Quality of Diffractive Enhanced Monofocal and Extended-Depth-of-Focus Intraocular Lenses.
Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Monofocal intraocular lens based on the Bessel principle for improved intermediate vision: a comparative assessment.BMC ophthalmology · 2026Article
- Early Real-World Outcomes with a Novel Hybrid Full Range of Vision Intraocular Lens.Medicina (Kaunas, Lithuania) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: We compared two hybrid refractive-diffractive IOLs with enhanced depth of focus in an in vitro study with regard to optical quality in monochromatic and polychromatic light as well as their ray-propagation behavior. Methods: The Mono-EDoF ME4 IOL (Santen Pharmaceutical, Osaka, Japan) and the Tecnis Symfony IOL (Johnson & Johnson Vision, USA) were assessed using the OptiSpheric IOL PRO 2 (Trioptics GmbH, Germany) to measure the through focus (TF) modulation transfer function (MTF) using monochromatic green (546 nm) and polychromatic light at different spatial frequencies. Ray propagation imaging was performed using monochromatic green light (520 nm) projected through each IOL, while submerged in a bath of fluorescein solution. The visual pathways were captured by a camera mounted on a microscope. Ray visualization was additionally performed for a monofocal control IOL (W60-R IOL, Santen Pharmaceutical). Results: The Mono-EDoF IOL showed superior TF-MTF performance for defocus of up to -1.3D compared to the Symfony IOL in monochromatic and polychromatic light. For higher defocus values, however, the Symfony showed superior performance than the Mono-EDoF. Image quality in polychromatic light decreased for both IOLs compared to monochromatic light. Ray propagation imaging revealed one distinct focus for the monofocal IOL. The Mono-EDoF demonstrated an elongated focus area. The Symfony showed two focal points. Conclusion: We found comparable deterioration of image quality in polychromatic light for both IOLs with improved intermediate range. The Mono-EDoF demonstrated an elongated focus and superior TF-MTF performance at lower defocus values, but it did not match the standard EDoF model at higher defocus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.